Innovative Translational Research Platform

WuXi Biology provides a full-range of in vivo and in vitro non-clinical pharmacodynamics evaluation programs and immune profile screening services.

Overview of our Facilities

  • 50,000 square foot facilities:
    • a Translational Research Center of Large Animal for Innovative Medicine
    • a Center for Bio-Medical Research & Testing
  • Offering models on non-human primates (NHP), canine and swine
  • AAALAC accreditation in 2022

Our Service for Translational Research

  • Biomarker Research and Tissue Banker
    • PBMC, FFPE, fresh frozen tissues, microbiome and other bio-specimens collected from non-human primates, canine and swine
    • Comprehensive strategy for the measurement of DNA, RNA and protein biomarker as pharmacodynamics readouts.
  • Animal pre-clinical pharmacodynamics models

Experience in inflammation, oncology and rare-diseases, including but not limit:

  • PBMC Immune Profiling
  • PDX, CDX, syngeneic tumor models
  • Ex vivo in vivo T cell activation
  • LPS-induced actue inflammation
  • Bioassay, Biosafety and Virus Testing
    • Bio-analysis for new modalities with method development and validation;
    • Mycoplasma, sterility, endotoxin and virus testing of cell lines, cell culture processes and biotherapeutics 

To learn more about immune profiling, biomarker and in vitro assays, please refer to below link: